Showing results (131-140 of 666) with videos related to
Sort By:
Pageof 67
Reviews in Urology|October 7, 2008
Prostate Cancer Specificity of PCA3 Gene Testing: Examples from Clinical PracticeLeonard S Marks, David G BostwickReviews in Urology|October 7, 2008
Overactive bladder: pharmacologic treatments in the neurogenic populationMichael J Kennelly, William B DevoeReviews in Urology|October 16, 2007
Twenty Years of PSA: From Prostate Antigen to Tumor MarkerGabriela De Angelis, Harry G Rittenhouse, Stephen D Mikolajczyk, et al.Reviews in Urology|January 12, 2007
Current concepts in ejaculatory dysfunctionJeffrey P Wolters, Wayne J G HellstromReviews in Urology|December 29, 2006
Prostate biopsy: targeting cancer for detection and therapySamir S TanejaReviews in Urology|December 29, 2006
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the artVictor W NittiReviews in Urology|June 8, 2007
High-risk, clinically localized prostate cancer: is monotherapy adequate?Mark H Katz, James M McKiernanReviews in Urology|June 27, 2007
The impact of definitions of failure on the interpretation of biochemical recurrence following treatment of clinically localized prostate cancerMatthew E Nielsen, Alan W PartinReviews in Urology|June 27, 2007
Management of men diagnosed with chronic prostatitis/chronic pelvic pain syndrome who have failed traditional managementJ Curtis Nickel, Andrew P Baranowski, Michel Pontari, et al.Reviews in Urology|June 27, 2007
Phosphodiesterase type 5 inhibitors for the treatment of male lower urinary tract symptomsSteven A Kaplan, Ricardo R GonzalezPageof 67